Intranasal fentanyl spray benefits compared with oral agents for breakthrough cancer pain

Intranasal fentanyl spray benefits compared with oral agents for breakthrough cancer pain

October 12, 2012

Patients with breakthrough cancer pain (BTCP) may want to consider intranasal fentanyl spray over oral agents to treat their breakthrough pain because of improved onset of analgesia and avoidance of nausea and vomiting, according to a report published online for The Annals of Pharmacotherapy.